Loading…
Company moves into broader extracorporeal therapy platform.
Nuwellis, Inc. announced the expansion of its Aquadex SmartFlow System into a broader extracorporeal therapy platform. This strategic move aims to enhance the system's capabilities and applications within the medical devices sector.
The expansion will allow Nuwellis to offer more comprehensive therapy options, potentially improving patient outcomes and increasing the system's market reach.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.